Across TCGA pan-cancer cohorts, RN7SL172P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RN7SL172P data layer.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RN7SL172P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RN7SL172P expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.
HNSC, LGG, and SKCM are the cancer types where RN7SL172P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.